Magnesium, Zinc and Copper in Lung Fibrosis: A Narrative Review
Medicina · 19.12.2025 · 62 (1) · 10
DOI: 10.3390/medicina62010010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicina, online erschienen am 19.12.2025. Verfasst von Mihai Nechifor und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, "Grigore T Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Zinc, Copper, Magnesium, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease with progressive evolution and high mortality. Magnesium, copper and zinc are essential biometals involved in numerous biological processes in all organs of the human body. A lower level of zinc and magnesium and a higher cooper/zinc ratio are frequently encountered in patients with idiopathic pulmonary fibrosis but also in other forms of pulmonary fibrosis. These imbalances are involved in the main pathogenic mechanisms of idiopathic pulmonary fibrosis: alveolar epithelial cell lesions, oxidative stress, inflammation, fibroblast and myofibroblast proliferation, mitochondrial activity, excessive extracellular matrix accumulation, high collagen production, alveolar macrophage dysfunctions, and apoptosis. A multitude of experimental and clinical studies have shown the importance of these bivalent cations for the synthesis or activity of some important endogenous active substances (fatty acids, eicosanoids, sirtuin1, p53 protein, interleukins, growth factors, some enzymes, and others) involved in one form or another in the pathogenesis of IPF. There are no randomized clinical trials yet, but some clinical and experimental results suggest that the association of zinc and magnesium with pirfenidone and nintedanib could be beneficial and should be assessed as soon as possible after the onset of this disease. The correction of hypomagnesemia and hypozincemia, whenever they exist, must be performed as soon as possible after the diagnosis of fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, "Grigore T Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Department of Histology, "Grigore T Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
ORCID-Profile: Mihai Nechifor, Carmen Lacramioara Zamfir
Zitieren
APA
Nechifor, M., Zamfir, C. L., & Gales, C. (2025). Magnesium, Zinc and Copper in Lung Fibrosis: A Narrative Review. Medicina, 62(1), 10. https://doi.org/10.3390/medicina62010010
Vancouver
Nechifor M, Zamfir CL, Gales C. Magnesium, Zinc and Copper in Lung Fibrosis: A Narrative Review. Medicina. 2025;62(1):10. doi:10.3390/medicina62010010
BibTeX
@article{Nechifor2025,
author = {Nechifor, Mihai and Zamfir, Carmen Lacramioara and Gales, Cristina},
title = {Magnesium, Zinc and Copper in Lung Fibrosis: A Narrative Review},
journal = {Medicina},
year = {2025},
volume = {62},
number = {1},
pages = {10},
doi = {10.3390/medicina62010010}
}
EUVIMED